EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological characteristics of Lynch-like syndrome

Sakiko Nakamori, Misato Takao, Akinari Takao, Soichiro Natsume, Takeru Iijima, Ekumi Kojika, Daisuke Nakano, Kazushige Kawai, Takuhiko Inokuchi, Ai Fujimoto, Makiko Urushibara, Shin-Ichiro Horiguchi und 2 weitere

International Journal of Clinical Oncology · 2024

DOI: 10.1007/s10147-024-02527-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Sakiko Nakamori und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, 113-8677, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Microsatellite Instability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lynch-like syndrome (LLS) has recently been proposed as a third type of microsatellite instability (MSI) tumor after Lynch syndrome (LS) and sporadic MSI colorectal cancer (CRC) without either a germline variant of mismatch repair (MMR) genes or hypermethylation of the MLH1 gene. The present study aimed to clarify and compare the clinicopathological characteristics of LLS with those of the other MSI CRC subtypes. METHODS: In total, 2634 consecutive patients with CRC who underwent surgical resection and subsequently received universal tumor screening (UTS), including MSI analysis were enrolled between January 2008 and November 2019. Genetic testing was performed in patients suspected of having Lynch syndrome. RESULTS: UTS of the cohort found 146 patients with MSI CRC (5.5%). Of these, excluding sporadic MSI CRC, 30 (1.1%) had a diagnosis of LS, and 19 (0.7%) had no germline pathogenic variants of the MMR gene. The CRC type in the latter group was identified as LLS. LLS occurred significantly more often in young patients, was left-sided, involved a KRAS variant and BRAF wild-type, and had a higher concordance rate with the Revised Bethesda Guidelines than sporadic MSI CRC. No significant differences were observed in terms of the clinicopathological factors between LLS and LS-associated MSI CRC; however, LLS had a lower frequency of LS-related neoplasms compared with LS. CONCLUSIONS: Distinguishing clinically between LS and LLS was challenging, but the incidence of neoplasms was higher in LS than in LLS, suggesting the need for different screening and surveillance methods for the two subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisMicrosatellite InstabilityHumansFemaleMaleMiddle AgedAgedAdultMutL Protein Homolog 1DNA Mismatch RepairProto-Oncogene Proteins B-rafAged, 80 and overProto-Oncogene Proteins p21(ras)Colorectal NeoplasmsGenetic Testing

Stichwörter der Autor:innen

Colorectal cancerGenetic testingLynch syndromeLynch-like syndromeMicrosatellite instability

Substanzen

MutL Protein Homolog 1Proto-Oncogene Proteins B-rafBRAF protein, humanMLH1 protein, humanProto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, 113-8677, Japan.
  • Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan.
  • Department of Clinical Genetics, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, 113-8677, Japan.
  • Hereditary Tumor Research Project, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, 113-8677, Japan.
  • Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, 113-8677, Japan.
  • Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, 350-8550, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nakamori, S., Takao, M., Takao, A., Natsume, S., Iijima, T., Kojika, E., Nakano, D., Kawai, K., Inokuchi, T., Fujimoto, A., Urushibara, M., Horiguchi, S. I., Ishida, H., & Yamaguchi, T. (2024). Clinicopathological characteristics of Lynch-like syndrome. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02527-x

Vancouver

Nakamori S, Takao M, Takao A, Natsume S, Iijima T, Kojika E, et al. Clinicopathological characteristics of Lynch-like syndrome. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02527-x

BibTeX
@article{Nakamori2024,
  author = {Nakamori, Sakiko and Takao, Misato and Takao, Akinari and Natsume, Soichiro and Iijima, Takeru and Kojika, Ekumi and Nakano, Daisuke and Kawai, Kazushige and Inokuchi, Takuhiko and Fujimoto, Ai and Urushibara, Makiko and Horiguchi, Shin-Ichiro and Ishida, Hideyuki and Yamaguchi, Tatsuro},
  title = {Clinicopathological characteristics of Lynch-like syndrome},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1007/s10147-024-02527-x}
}
Kostenlos starten →